Detection of Chlamydia trachomatis in symptomatic and asymptomatic populations with urogenital specimens by AMP CT (Gen-probe incorporated) compared to others commercially available amplification assays.
about
Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitorsComparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.
P2860
Detection of Chlamydia trachomatis in symptomatic and asymptomatic populations with urogenital specimens by AMP CT (Gen-probe incorporated) compared to others commercially available amplification assays.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Detection of Chlamydia trachom ...... vailable amplification assays.
@en
Detection of Chlamydia trachom ...... urogenital specimens by AMP CT
@nl
type
label
Detection of Chlamydia trachom ...... vailable amplification assays.
@en
Detection of Chlamydia trachom ...... urogenital specimens by AMP CT
@nl
prefLabel
Detection of Chlamydia trachom ...... vailable amplification assays.
@en
Detection of Chlamydia trachom ...... urogenital specimens by AMP CT
@nl
P2093
P1476
Detection of Chlamydia trachom ...... vailable amplification assays.
@en
P2093
P304
P356
10.1016/S0732-8893(00)00143-7
P577
2000-07-01T00:00:00Z